Bicara Therapeutics Financial Statements 2023-2025 | BCAX

Fifteen years of historical annual and quarterly income statements for Bicara Therapeutics (BCAX).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM20242023
$0.00$0$0
$0.00$0$0
$0.00$0$0
$22.80$63.62$30.62
$7.36$18.77$9.27
$0.00$0$0
$0.00$0$0
$-30.16$-82.39$-39.89
$-10.17$14.58$-12.09
$-40.33$-67.81$-51.98
$0.00$0.19$0.01
$-40.33$-68.00$-51.99
$0.00$0$0
$-40.33$-68.00$-51.99
$0.00$0$0
$-40.33$-68.00$-51.99
$-30.16$-82.33$-39.87
$-30.16$-82.39$-39.89
$-39.83$-4.05$-89.61
$-39.83$-4.05$-89.61

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2024-12-312024-09-302023-12-312023-09-30
$0$0$0$0
$0$0$0$0
$0$0$0$0
$0$15.86$0$6.94
$0$4.76$0$2.59
$0$0$0$0
$0$0$0$0
$0$-20.63$0$-9.53
$0$3.15$0$-13.32
$0$-17.48$0$-22.85
$0$0.00$0$0.00
$0$-17.48$0$-22.85
$0$0$0$0
$0$-17.48$0$-22.85
$0$0$0$0
$0$-17.48$0$-22.85
$0$-20.63$0$-9.53
$0$-20.63$0$-9.53
$0$-1.60$0$-38.23
$0.00$-1.60$0.00$-38.23